(a) whether the liabilities of only 22 companies have been quantified by the Drug Price Liability Review Committee (DPLRC);
(b) if so, the details and outcome thereof and the reaction of the Government thereto; and
(c) the reasons for only Indian companies picked up by the DPLRC and not quantifying the amounts of some Multi National Companies (MNCs)?
THE MINISTER OF CHEMICALS AND FERTILIZERS AND MINISTER OF STEEL (SHRI RAM VILAS PASWAN):
(a) and (b) The DPEA liability in respect of 24 companies has so far been quantified by the
Drug Prices Liabilities Review Committee (DPLRC). The details are given in the enclosed
Statement. On the basis of the recommendations of the Committee, action has been initiated
to recover the amount of liability from the drug companies concerned.
(c) The DPLRC has been quantifying the liabilities of the drug companies bulk drug-wise as far
as possible. While quantifying the liability, on distinction is made by the Committee between
Indian companies and Multi National Companies (MNC).